Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Feb 17;12:646523. doi: 10.3389/fimmu.2021.646523

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 Cheng, Wang, Nie, Cheng, Zhang, Hu and Peng.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Correlation between TREM2 expression and gene promoter methylation. (A) Correlation between TREM2 expression and gene promoter methylation in brain lower grade glioma (LGG), glioblastoma multiforme (GBM), uveal melanoma (UVM), kidney chromophobe (KICH), mesothelioma (MESO), and lung squamous cell carcinoma (LUSC). (B) Correlation between TREM2 methylation overall survival in MESO, UVM, and liver hepatocellular carcinoma (LIHC). (C) Correlation between TREM2 methylation and disease-specific survival in UVM and kidney renal papillary cell carcinoma (KIRP). (D) Correlation between TREM2 methylation and disease-free interval in KIRP. (E) Correlation between TREM2 methylation and progression-free interval in KICH, kidney renal papillary cell carcinoma (KIPR), LGG, MESO, and prostate adenocarcinoma (PRAD).